Form 4 for PODD Insulet Corporation
Accepted 2022-04-05 00:00:00 ET · period of report 2022-03-17 · accession 0001127602-22-011550 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-05 | 2022-03-17 | PODD | Petrovic Shacey | Pres, CEO, Dir | G - Gift | $0.00 | -19.9K | 13.6K | -59% | $0 |
| DI | 2022-04-05 | 2022-03-17 | PODD | Petrovic Shacey | Pres, CEO, Dir | G - Gift | $0.00 | +19.9K | 26.3K | +311% | $0 |
| D | 2022-04-05 | 2022-04-04 | PODD | Petrovic Shacey | Pres, CEO, Dir | S - Sale+OE | $273.25 | -15.0K | 13.6K | -52% | -$4.10M |
| D | 2022-04-05 | 2022-04-04 | PODD | Petrovic Shacey | Pres, CEO, Dir | M - OptEx | $29.26 | +15.0K | 28.6K | +110% | +$438.9K |
| D | 2022-04-05 | 2022-04-04 | PODD | Petrovic Shacey | Pres, CEO, Dir | M - OptEx | $0.00 | -15.0K | 7,070 | -68% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-17 | G | D | 19,903 | $0.00 | 13,607 | D By SP Trust | — | — | (F1) On March 17, 2022, the reporting person transferred 19,903 shares of Insulet common stock to a family trust of which the reporting person is a trustee. The reporting person and members of her immediate family are beneficiaries of the trust. |
| 2 | Common | Common Stock | 2022-03-17 | G | A | 19,903 | $0.00 | 26,304 | I | — | — | (F1) On March 17, 2022, the reporting person transferred 19,903 shares of Insulet common stock to a family trust of which the reporting person is a trustee. The reporting person and members of her immediate family are beneficiaries of the trust. |
| 3 | Common | Common Stock | 2022-04-04 | S | D | 15,000 | $273.25 | 13,607 | D | — | — | (F2) The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. (F3) The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $270.79 to $279.59. Specifically: 4,146 shares were sold in the range of $270.79 to $271.77 per share, with a weighted average share price of $271.35; 1,928 shares were sold in the range of $271.79 to $272.73 per share, with a weighted average share price of $272.10; 3,111 shares were sold in the range of $272.80 to $273.77 per share, with a weighted average share price of $273.30; 3,618 shares were sold in the range of $273.78 to $274.77 per share, with a weighted average share price of $274.21; 1,413 shares were sold in the range of $274.78 to $275.35 per share, with a weighted average share price of $275.08; 200 shares were sold in the range of $276.09 to $276.37 per share, with a weighted average share price of $276.23; 142 shares were sold in the range of $277.64 to $278.39 per share, with a weighted average share price of $278.20 and 442 shares were sold in the range of $278.66 to $279.59 per share, with a weighted average share price of $279.28. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2022-04-04 | M | A | 15,000 | $29.26 | 28,607 | D | — | — | (F2) The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2022-04-04 | M | D | 15,000 | $0.00 | 7,070 | D | $29.26 · — to 2026-02-24 | 15,000 Common Stock | (F4) This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment. |